Category: platform economy
-
Re-shoring the Future: How Pharma’s Return to U.S. Soil Redefines the Global Biotech Map
The New Geography of Medicine The global pharmaceutical and biotechnology industries are entering a new phase of geographic realignment. Major companies such as Biogen, Merck, and Amgen have recently announced multi-billion-dollar investments to expand their U.S. manufacturing bases—particularly in biologics, gene therapies, and advanced therapeutics.This trend, described by analysts as…